Geron Corp
NASDAQ:GERN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Geron Corp
NASDAQ:GERN
|
US |
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
|
Palantir Technologies Inc
MIL:1PLTR
|
US |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Anglo American Platinum Ltd
OTC:AGPPF
|
ZA |
|
M
|
Microchip Technology Inc
XHAM:MCP
|
US |
|
A
|
Akamai Technologies Inc
XHAM:AK3
|
US |
|
I
|
Illumina Inc
DUS:ILU
|
US |
|
Industria de Diseno Textil SA
F:IXD2
|
ES |
|
Ameris Bancorp
F:AXU
|
US |
|
P
|
Pacific Biosciences of California Inc
SWB:P09
|
US |
|
KLX Energy Services Holdings Inc
F:KX4A
|
US |
|
B
|
Bank of America Corp
F:NCB
|
US |
|
E
|
Exor NV
VSE:EXO
|
NL |
|
S
|
Service Corporation International
XBER:SVC
|
US |
|
F
|
Fastenal Co
SWB:FAS
|
US |
|
China Coal Energy Co Ltd
OTC:CCOZF
|
CN |
|
Tompkins Financial Corp
F:8J0
|
US |
Wall St Price Targets
GERN Price Targets Summary
Geron Corp
According to Wall Street analysts, the average 1-year price target for
GERN is 3.47 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GERN's stock price target?
Price Target
3.47
USD
According to Wall Street analysts, the average 1-year price target for
GERN is 3.47 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Geron Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Geron Corp?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 8 years is 20%.